Skye Bioscience, Inc. (SKYE)

CIK 1516551 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Skye Bioscience, Inc..

Recent SEC filings

FiledFormAccession number
Sep 11, 20268-K0001628280-26-061558
Sep 11, 2026DEFA14A0001628280-26-061564
Aug 24, 2026DEFA14A0001628280-26-058615
Aug 24, 20268-K0001628280-26-058605
Aug 20, 202640001598549-26-000005
Aug 20, 20268-K/A0001628280-26-058120
Aug 20, 202640001231919-26-000959
Aug 20, 2026DEFA14A0001628280-26-058121
Aug 19, 2026DEFA14A0001628280-26-057806
Aug 19, 20268-K0001628280-26-057804
Aug 18, 2026SCHEDULE 13D/A0001873545-26-000007
Aug 14, 2026DEFA14A0001628280-26-056979
Aug 14, 202610-Q0001628280-26-056968
Aug 14, 20268-K0001628280-26-056966
Aug 7, 202640001628280-26-054941
Jun 23, 20268-K0001628280-26-044747
May 29, 20268-K0001628280-26-039233
May 15, 20268-K0001628280-26-035535
May 11, 202610-Q0001628280-26-033417
Apr 28, 202630001628280-26-028062
Apr 16, 2026DEFA14A0001628280-26-025369
Apr 16, 2026ARS0001628280-26-025370
Apr 16, 2026DEF 14A0001628280-26-025368
Apr 6, 20268-K/A0001628280-26-023903
Apr 6, 2026PREM14A0001628280-26-023908